Interestingly, recent work by Woerman et al. has shown that the seeding potential of the patient-derived tau aggregates in AD and CTE could be distinguished from that of other tauopathies (PiD, AGD, CBD, and PSP) using a panel of tau-YFP reporter cell models [272]. The gene discussed is MAPT; the disease is argyrophilic grain disease.